Construction Business Review Conferences

UK Biotech Day is an international premier event for life science leaders, innovators, investors and service providers. Our mission is to unite the UK’s vibrant biotech ecosystem, spanning world-class research, dynamic startups, big pharma, and visionary investors, to drive breakthrough partnerships. Join us to discover new opportunities, forge strategic alliances, and help shape the next era of biotech success in the UK and the world.

The Global Bioprocessing & Biotechnology Summit 2026 will unite leading industry experts, researchers, and innovators to explore the latest breakthroughs in bio manufacturing. With a focus on enhancing efficiency, sustainability, and cutting-edge technologies, these events are designed to accelerate the future of bioprocessing. In a world where every cell holds the key to discovery, the Bioprocessing Summit serves as the catalyst for unraveling the complexities of advanced therapeutic interventions.

The Pharma & Biotech Quality Summit, scheduled for 12–13 May 2026 in Munich, convenes senior leaders from quality and manufacturing functions to address the evolving role of quality in an increasingly complex pharmaceutical landscape. A strong focus is placed on emerging challenges in advanced therapies and personalized medicine, where distributed manufacturing models and complex supply chains require new approaches to quality oversight and control. For business leaders, the event provides a platform to benchmark strategies, assess emerging risks and explore how quality can contribute to long-term value creation in pharma and biotech.

Alliance Management is emerging as a key driver of innovation and growth, blending digital tools, AI, and cultural fluency. The conference explores evolving pharma and biotech partnerships across the full lifecycle, focusing on value creation, governance, and new collaboration models.

This event will bring together senior S&OP, IBP, supply chain and finance leaders from Pharma and Life Sciences to share practical case studies and peer insights on how to connect planning, performance and decision-making across the organisation. The event will enable attendees to understand the key priorities in a context of volatility, regulatory complexity and long planning horizons, and to benchmark how peers integrate finance, demand, supply, portfolio and execution to move from traditional S&OP towards enterprise-wide IBP.

Explore solutions to R&D’s biggest hurdles: funding uncertainty, proving innovation’s value, and balancing openness with creative freedom. Gain tools and real cases to turn risk into strategy - learn to build adaptable budgets, link innovation to business impact, and position R&D as a driver of growth.

BioPharma Deals: The Survival Series brings together leaders from biotech, pharma, investment, CRO/CDMO, legal, and advisory sectors for a high-impact event focused on pragmatic deal-making, new financing models, early IPOs, and unconventional partnerships. This is not a conference about the distant future. It's a working summit for what can be done now. It's about survival, smart positioning, and forging the partnerships that will keep your company alive and help you grow. Come to learn, network, and leave with tangible ideas and new connections that could change your company's trajectory.

The London Biotechnology Show is a premier biotechnology event taking place in the United Kingdom to expedite the progress of biotechnology for revolutionising the medical & healthcare sectors in the region and across the globe. The 2nd edition of the London Biotechnology Show will offer an impeccable event experience for the participants to discover the latest technological advancements & ground-breaking offerings and simultaneously deliberate on the ways to widen the scope of red biotechnology across the globe.

“I had the pleasure of meeting and interacting with scientists, colleagues, collaborators and friends while enjoying talks and discussions on vaccines, infectious diseases and pandemic preparedness for the future. ”

The start-up zone will provide a unique environment to meet VCs looking for early stage opportunities as well as companies across pharma, biotech, healthcare, academia, chemicals, food, animal health and the community that serves them.